Mark C. Schneyer, EVP, CFO: Acadia Pharmaceuticals ACAD Sell · Filed 23/02/27

Trade details

Type: Insider sale
Amount: $10,836.06
Shares · price: 577 sh · $18.78 a share
Held after: 4,118 sh
Stock: Acadia Pharmaceuticals ACAD
Person: Mark C. SchneyerEVP, CFO
Trade date: 23/02/24
Filed: 23/02/27
Days to filing: 3 days

Sold 12.3% of holdings

Share of holding sold: 12.3%

Acadia Pharmaceuticals trades, last 26 weeks

What else happened in Acadia Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/01/25~23/03/26

Mark C. Schneyer's recent trades

Mark C. SchneyerEVP, CFO
Planned sale10b5-1 planAcadia Pharmaceuticals
Planned sale10b5-1 plan
Acadia Pharmaceuticals
ACAD
$158.8K
5,849 sh
$158.8K
Filed 08/05
Traded 08/05
Mark C. SchneyerEVP, CFO
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$76.4K
3,506 sh
$76.4K
Filed 05/05
Traded 05/04
Mark C. SchneyerEVP, CFO
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$60.1K
2,709 sh
$60.1K
Filed 04/07
Traded 04/07
Mark C. SchneyerEVP, CFO
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$89.7K
4,177 sh
$89.7K
Filed 03/26
Traded 03/25
Mark C. SchneyerEVP, CFO
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$68.7K
3,171 sh
$68.7K
Filed 03/26
Traded 03/26

Mark C. Schneyer, CFO — sold $10.8K of Acadia Pharmaceuticals ACAD · 12.3% of holdings | Whalegun